カテゴリ： MarketsandMarkets, 世界, 医療/バイオ

空間ゲノミクス＆トランスクリプトミクスの世界市場予測（～2027）：技術別、製品別、用途別、エンドユーザー別

■ 英語タイトル：Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027

調査会社MarketsandMarkets社が発行したリサーチレポート（データ管理コード：BT7790-23）■ 発行会社/調査会社：MarketsandMarkets
■ 商品コード：BT7790-23
■ 発行日：2022年12月20日
■ 調査対象地域：グローバル
■ 産業分野：バイオテクノロジー
■ ページ数：232
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[空間ゲノミクス＆トランスクリプトミクスの世界市場予測（～2027）：技術別、製品別、用途別、エンドユーザー別]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

MarketsandMarkets社は、世界の空間ゲノミクス＆トランスクリプトミクス市場規模が2022年355百万ドルから2027年800百万ドルに達し、予測期間中に年平均17.6％で成長すると予測しています。本調査資料では、空間ゲノミクス＆トランスクリプトミクスの世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、技術別（空間トランスクリプトミクス、空間ゲノミクス解析）分析、製品別（消耗品、装置、ソフトウェア）分析、用途別（橋渡し研究、創薬）分析、エンドユーザー別（学術＆研究機関、受託研究機関、製薬企業＆バイオテクノロジー企業）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの内容を掲載しています。また、本レポートに掲載されている企業情報には、NanoString Technologies,Inc. (US)、10X Genomics (US)、Illumina (US)、Bio-Rad Laboratories (US)、Bio-Techne Corporation (US)、Standard BioTools Inc. (US)、Genomic Vision SA (France)、Akoya Biosciences,Inc. (US)、Danaher Corporation (US)、Natera,Inc. (US)、PerkinElmer,Inc. (US)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の空間ゲノミクス＆トランスクリプトミクス市場規模：技術別
- 空間トランスクリプトミクス技術の市場規模
- 空間ゲノミクス解析技術の市場規模
・世界の空間ゲノミクス＆トランスクリプトミクス市場規模：製品別
- 消耗品の市場規模
- 装置の市場規模
- ソフトウェアの市場規模
・世界の空間ゲノミクス＆トランスクリプトミクス市場規模：用途別
- 橋渡し研究における市場規模
- 創薬における市場規模
・世界の空間ゲノミクス＆トランスクリプトミクス市場規模：エンドユーザー別
- 学術＆研究機関における市場規模
- 受託研究機関における市場規模
- 製薬企業＆バイオテクノロジー企業における市場規模
・世界の空間ゲノミクス＆トランスクリプトミクス市場規模：地域別
- 北米の空間ゲノミクス＆トランスクリプトミクス市場規模
- ヨーロッパの空間ゲノミクス＆トランスクリプトミクス市場規模
- アジア太平洋の空間ゲノミクス＆トランスクリプトミクス市場規模
- 中南米の空間ゲノミクス＆トランスクリプトミクス市場規模
- 中東・アフリカの空間ゲノミクス＆トランスクリプトミクス市場規模
・競争状況
・企業情報

“世界の空間ゲノミクス＆トランスクリプトミクス市場は、2022年の3億5500万米ドルから2027年には8億米ドルに達し、予測期間中のCAGRは17.6%と予想”
市場成長の主な原動力は、厳密な研究用途から、神経変性疾患やがんなどの分野の創薬・薬剤開発へのシフトです。また、空間ゲノミクス＆トランスクリプトミクスは、反応予測バイオマーカーの需要など、現在満たされていない腫瘍学の臨床ニーズに対応することが期待されています。これらのバイオマーカーは、腫瘍の理解を深めることで免疫療法の開発に役立ちます。その一方で、トランスクリプトミクス研究の成果が明確でないことと、装置のコストが高いことが、トランスクリプトミクス技術の採用を抑制し、空間ゲノミクス＆トランスクリプトミクス市場の成長を制限しています。

“アプリケーション別では、トランスレーショナルリサーチが空間ゲノミクス＆トランスクリプトミクス市場で最大のシェアを占める”
アプリケーションに基づき、空間ゲノミクス＆トランスクリプトミクス市場はトランスレーショナルリサーチと創薬＆開発に分類されます。トランスレーショナルリサーチ分野は、政府や非政府組織による研究助成金や資金提供の増加により、2021年の市場を占めました。

“アジア太平洋地域： 空間ゲノミクス＆トランスクリプトミクス市場で最も成長著しい地域”
アジア太平洋市場は予測期間中に最も高いCAGRで成長すると予測されていますが、これは主にバイオ医薬品産業の成長によるもので、アジア諸国における研究開発費の増加は成長を促進する主な要因の1つです。加えて、アジア諸国は技術革新と商業化を促進するために規制、政策、ガイドラインを修正しており、多くの国内実業家や世界的な市場リーダーがこの地域で事業を立ち上げるよう誘致しています。
 
“北米：空間ゲノミクス＆トランスクリプトミクス市場で最大シェア”
空間ゲノミクス＆トランスクリプトミクス市場で最大のシェアを占めたのは北米です。慢性疾患の罹患率の上昇、新たな再生医療開発のための研究資金の増加、さまざまな癌を治療するための技術進歩や細胞療法の発売などの要因が、市場成長を促進する主な要因となっています。

本レポートのために実施した一次インタビューは以下のように分類されます：

– 回答者別 供給側60％、需要側40％
– 役職別 経営幹部：40%、研究者：30%、管理職：30％
– 地域別 北米：51％、欧州：25％、アジア太平洋地域：18％、中南米：3％、中東・アフリカ：3％

主要プレイヤー
• NanoString Technologies, Inc. (US)
• 10X Genomics (US)
• Illumina (US)
• Bio-Rad Laboratories (US)
• Bio-Techne Corporation (US)
• Standard BioTools Inc. (US)
• Genomic Vision SA (France)
• Akoya Biosciences, Inc. (US)
• Danaher Corporation (US)
• Natera, Inc. (US)
• PerkinElmer, Inc. (US)
• Seven Bridges Genomics (US)
• S2 Genomics, Inc. (US)
• Cantata Bio (US)
• Vizgen Corporation (US)
• BioSpyder Technologies Inc. (US)
• Optical Biosystems Inc. (US)
• Miltenyi Biotec (Germany)
• Ultivue Inc. (US)
• Lunaphore Technologies SA (Switzerland)
• Rebus Biosystems LLC (US)
• Resolve Biosciences (Germany)
• Singular Genomics, Inc. (US)
• Veracyte (US)

調査範囲
この調査レポートは、空間ゲノミクス＆トランスクリプトミクス市場を詳細に掲載しています。製品、技術、用途、エンドユーザー、地域など、さまざまなセグメントにわたる市場規模と今後の成長可能性を推定することを目的としています。また、主要市場プレイヤーの企業プロフィール、最近の動向、主要市場戦略とともに、詳細な競合分析も掲載しています。

レポート購入の主な利点
本レポートは、空間ゲノミクス＆トランスクリプトミクス市場全体とそのセグメントの収益数の最も近い概算値を提供することで、市場リーダー／新規参入者を支援します。また、利害関係者が競合状況をよりよく理解し、自社のビジネスをよりよく位置づけ、適切な市場参入戦略を立てるための洞察を深めるのにも役立ちます。本レポートにより、関係者は市場動向を理解し、主要な市場促進要因、阻害要因、動向、機会、課題に関する情報を得ることができます。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.2.1 INCLUSIONS & EXCLUSIONS 35
1.3 STUDY SCOPE 36
1.4 YEARS CONSIDERED 37
1.5 CURRENCY CONSIDERED 37
1.6 LIMITATIONS 37
1.7 STAKEHOLDERS 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH DATA 38
FIGURE 1 RESEARCH DESIGN 38
2.1.1 SECONDARY DATA 38
2.1.2 PRIMARY DATA 39
FIGURE 2 BREAKDOWN OF PRIMARIES: SPATIAL GENOMICS AND TRANSCRIPTOMICS MARKET 40
2.2 MARKET ESTIMATION METHODOLOGY 40
FIGURE 3 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 40
FIGURE 4 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SIZE,
2021 (USD MILLION) 41
FIGURE 5 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: FINAL CAGR PROJECTIONS (2022−2027) 41
FIGURE 6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, AND CHALLENGES 42
2.3 MARKET DATA ESTIMATION & TRIANGULATION 43
2.3.1 DATA TRIANGULATION 43
FIGURE 7 DATA TRIANGULATION METHODOLOGY 43
2.4 INDUSTRY INSIGHTS 44
2.5 RESEARCH ASSUMPTIONS 44
3 EXECUTIVE SUMMARY 45
FIGURE 8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT,
2021 VS. 2027 (USD MILLION) 45
FIGURE 9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE,
2021 VS. 2027 (USD MILLION) 46
FIGURE 10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY APPLICATION, 2021 VS. 2027 46
FIGURE 11 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER,
2021 VS. 2027 (USD MILLION) 47
FIGURE 12 GEOGRAPHICAL SNAPSHOT 48
4 PREMIUM INSIGHTS 49
4.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET OVERVIEW 49
FIGURE 13 INCREASING ADOPTION OF SPATIAL GENOMICS & TRANSCRIPTOMICS ANALYSIS IN TRANSLATIONAL RESEARCH TO DRIVE MARKET GROWTH 49
4.2 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE,
BY PRODUCT & COUNTRY (2021) 50
FIGURE 14 CONSUMABLES ACCOUNTED FOR LARGEST SHARE IN 2021 50
4.3 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SHARE, BY END USER (2021) 51
FIGURE 15 ACADEMIC & RESEARCH INSTITUTES ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MARKET DYNAMICS 52
FIGURE 16 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52
TABLE 1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: IMPACT ANALYSIS 53
5.2.1 DRIVERS 53
5.2.1.1 Increasing adoption of spatial genomics & transcriptomics in drug discovery & development 53
5.2.1.2 Introduction of novel products 54
5.2.1.3 Increasing R&D investments and public-private funding 54
5.2.2 RESTRAINTS 55
5.2.2.1 High capital investments 55
5.2.3 OPPORTUNITIES 55
5.2.3.1 Increasing use of spatial omics for biomarker identification 55
5.2.4 CHALLENGES 56
5.2.4.1 Dearth of skilled professionals 56
5.3 TECHNOLOGY ANALYSIS 56
5.3.1 MULTIPLEXING 56
5.3.2 IMAGING-BASED TECHNOLOGICAL ADVANCEMENTS 56
5.3.3 DATA ANALYSIS 56
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 57
FIGURE 17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 57
5.5 SUPPLY CHAIN ANALYSIS 57
FIGURE 18 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: SUPPLY CHAIN ANALYSIS 58
5.6 VALUE CHAIN ANALYSIS 58
FIGURE 19 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: VALUE CHAIN ANALYSIS 58
5.7 ECOSYSTEM ANALYSIS 59
FIGURE 20 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: ECOSYSTEM ANALYSIS 59
5.8 PORTER’S FIVE FORCES ANALYSIS 59
TABLE 2 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.8.1 THREAT OF NEW ENTRANTS 60
5.8.2 THREAT OF SUBSTITUTES 60
5.8.3 BARGAINING POWER OF BUYERS 60
5.8.4 BARGAINING POWER OF SUPPLIERS 60
5.8.5 DEGREE OF COMPETITION 60
5.9 REGULATORY ANALYSIS 61
5.9.1 FDA APPROVALS 61
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 61
TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62
TABLE 6 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 62
5.10 PRICING ANALYSIS 63
TABLE 7 PRICING ANALYSIS OF SPATIAL GENOMICS AND TRANSCRIPTOMICS PRODUCTS 63
5.10.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: AVERAGE SELLING PRICE TREND 63
5.11 PIPELINE ANALYSIS 63
5.12 KEY CONFERENCES & EVENTS IN 2022–2023 64
5.12.1 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023) 64
TABLE 8 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONFERENCES (2022-2023) 64
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 64
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 64
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 64
5.13.2 BUYING CRITERIA FOR SPATIAL GENOMICS AND TRANSCRIPTOMICS 65
FIGURE 22 KEY BUYING CRITERIA FOR END USERS 65
6 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE 66
6.1 INTRODUCTION 67
TABLE 9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 67
6.2 SPATIAL TRANSCRIPTOMICS 67
TABLE 10 SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 68
TABLE 11 SPATIAL TRANSCRIPTOMICS MARKET, BY REGION,
2020–2027 (USD MILLION) 68
TABLE 12 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 68
TABLE 13 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69
TABLE 14 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 69
TABLE 15 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 69
TABLE 16 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 70
6.2.1 IMMUNOHISTOCHEMISTRY 70
6.2.1.1 Emergence of mIHC/IF to propel growth 70
TABLE 17 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2020–2027 (USD MILLION) 70
TABLE 18 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 19 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 20 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71
TABLE 21 LATIN AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
TABLE 22 MIDDLE EAST & AFRICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 72
6.2.2 IN SITU HYBRIDIZATION 72
6.2.2.1 High adoption of MERFISH to drive growth 72
TABLE 23 IN SITU HYBRIDIZATION MARKET, BY REGION, 2020–2027 (USD MILLION) 73
TABLE 24 NORTH AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 25 EUROPE: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 26 ASIA PACIFIC: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 27 LATIN AMERICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
TABLE 28 MIDDLE EAST & AFRICA: IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74
6.2.3 SEQUENCING 75
TABLE 29 SEQUENCING MARKET, BY REGION, 2020–2027 (USD MILLION) 75
TABLE 30 NORTH AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 31 EUROPE: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 76
TABLE 32 ASIA PACIFIC: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 76
TABLE 33 LATIN AMERICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 76
TABLE 34 MIDDLE EAST & AFRICA: SEQUENCING MARKET FOR TRANSCRIPTOMICS, BY COUNTRY, 2020–2027 (USD MILLION) 77
6.2.3.1 Microdissection-based sequencing 77
6.2.3.1.1 Increasing use of microdissection-based sequencing to contribute to market growth 77
6.2.3.2 In situ sequencing 77
6.2.3.2.1 Increased adoption of in situ sequencing likely to boost market growth 77
6.2.4 OTHER SEQUENCING TECHNOLOGIES 78
6.2.5 MICROSCOPY-BASED RNA IMAGING 78
6.2.5.1 Rising use of microscopy-based RNA imaging in cancer research and diagnosis to drive growth 78
TABLE 35 MICROSCOPY-BASED RNA IMAGING MARKET, BY REGION, 2020–2027 (USD MILLION) 79
TABLE 36 NORTH AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
TABLE 37 EUROPE: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 79
TABLE 38 ASIA PACIFIC: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 39 LATIN AMERICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
TABLE 40 MIDDLE EAST & AFRICA: MICROSCOPY-BASED RNA IMAGING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 80
6.2.6 OTHER SPATIAL TRANSCRIPTOMICS TECHNIQUES 81
6.3 SPATIAL GENOMICS ANALYSIS 81
TABLE 41 SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 81
TABLE 42 SPATIAL GENOMICS ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION) 81
TABLE 43 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 44 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 45 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 82
TABLE 46 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
TABLE 47 MIDDLE EAST & AFRICA: OTHER SPATIAL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.1 FLUORESCENCE IN SITU HYBRIDIZATION 83
6.3.1.1 Emerging potential of spatial genomics analysis in cancer diagnostics to support market growth 83
TABLE 48 FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY REGION, 2020–2027 (USD MILLION) 84
TABLE 49 NORTH AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 50 EUROPE: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 51 ASIA PACIFIC: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 52 LATIN AMERICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
TABLE 53 MIDDLE EAST & AFRICA: FLUORESCENCE IN SITU HYBRIDIZATION MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.3.2 SEQUENCING 86
6.3.2.1 Rising adoption of massively parallel sequencing to drive growth 86
TABLE 54 SEQUENCING TECHNIQUES MARKET FOR SPATIAL GENOMICS ANALYSIS, BY REGION, 2020–2027 (USD MILLION) 86
TABLE 55 NORTH AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 86
TABLE 56 EUROPE: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 57 ASIA PACIFIC: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 58 LATIN AMERICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
TABLE 59 MIDDLE EAST & AFRICA: SEQUENCING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 88
6.3.3 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES 88
TABLE 60 OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY REGION, 2020–2027 (USD MILLION) 88
TABLE 61 NORTH AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 62 EUROPE: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 63 ASIA PACIFIC: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
TABLE 64 LATIN AMERICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 65 MIDDLE EAST & AFRICA: OTHER SPATIAL GENOMICS ANALYSIS TECHNIQUES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 90
7 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT 91
7.1 INTRODUCTION 92
TABLE 66 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 92
7.2 CONSUMABLES 92
7.2.1 GROWING USE OF CONSUMABLES FOR VARIOUS SPATIAL GENOMICS AND TRANSCRIPTOMICS APPLICATIONS TO DRIVE MARKET GROWTH 92
TABLE 67 SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION) 93
TABLE 68 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 69 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 70 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 71 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 72 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.3 INSTRUMENTS 95
7.3.1 INTRODUCTION OF NOVEL INSTRUMENTS TO DRIVE MARKET 95
TABLE 73 SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 95
TABLE 74 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 75 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 76 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 77 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 78 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.4 SOFTWARE 97
7.4.1 RISING USE OF SPATIAL OMICS FOR DISEASE DIAGNOSIS TO PROPEL DEMAND FOR SOFTWARE 97
TABLE 79 SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION) 98
TABLE 80 NORTH AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 81 EUROPE: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
TABLE 82 ASIA PACIFIC: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 83 LATIN AMERICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
TABLE 84 MIDDLE EAST & AFRICA: SPATIAL GENOMICS AND TRANSCRIPTOMICS SOFTWARE MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 99
8 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION 100
8.1 INTRODUCTION 101
TABLE 85 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101
8.2 TRANSLATIONAL RESEARCH 101
8.2.1 DEMAND FOR SPATIAL TRANSCRIPTOMICS IN UNDERSTANDING TUMOR MICROENVIRONMENT TO DRIVE SEGMENT GROWTH 101
TABLE 86 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY REGION, 2020–2027 (USD MILLION) 102
TABLE 87 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 88 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 102
TABLE 89 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 90 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 91 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR TRANSLATIONAL RESEARCH, BY COUNTRY, 2020–2027 (USD MILLION) 103
8.3 DRUG DISCOVERY & DEVELOPMENT 104
8.3.1 RISING USE OF RNA-SEQ IN DRUG DISCOVERY TO DRIVE MARKET 104
TABLE 92 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020–2027 (USD MILLION) 104
TABLE 93 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 94 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 95 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 105
TABLE 96 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 97 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020–2027 (USD MILLION) 106
9 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER 107
9.1 INTRODUCTION 108
TABLE 98 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 108
9.2 ACADEMIC & RESEARCH INSTITUTES 108
9.2.1 INCREASED DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS IN TRANSLATIONAL RESEARCH TO DRIVE GROWTH 108
TABLE 99 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2020–2027 (USD MILLION) 109
TABLE 100 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 101 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 102 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 103 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 104 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 110
9.3 CONTRACT RESEARCH ORGANIZATIONS 111
9.3.1 INCREASING DEPENDENCE ON CONTRACT RESEARCH TO DRIVE MARKET 111
TABLE 105 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 106 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 107 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 108 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 109 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 110 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 113
9.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 113
9.4.1 GROWING IMPORTANCE OF BIOMARKERS TO DRIVE DEMAND FOR SPATIAL GENOMICS & TRANSCRIPTOMICS SYSTEMS 113
TABLE 111 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 113
TABLE 112 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 113 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 114 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 114
TABLE 115 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 116 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 115
10 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION 116
10.1 INTRODUCTION 117
FIGURE 23 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION, 2022 VS. 2027 (USD MILLION) 117
TABLE 117 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY REGION, 2020–2027 (USD MILLION) 117
10.2 NORTH AMERICA 118
FIGURE 24 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT 118
TABLE 118 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 119 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 119
TABLE 120 NORTH AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 119
TABLE 121 NORTH AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 120
TABLE 122 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 120
TABLE 123 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 120
TABLE 124 NORTH AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 121
10.2.1 US 121
10.2.1.1 US to dominate North American market 121
TABLE 125 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 121
TABLE 126 US: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 127 US: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 128 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 129 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 130 US: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 123
10.2.2 CANADA 123
10.2.2.1 Government initiatives to contribute to market growth 123
TABLE 131 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 124
TABLE 132 CANADA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 133 CANADA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 124
TABLE 134 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 135 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 125
TABLE 136 CANADA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 125
10.3 EUROPE 126
TABLE 137 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 138 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 126
TABLE 139 EUROPE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 140 EUROPE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 127
TABLE 141 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 142 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 143 EUROPE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 128
10.3.1 GERMANY 128
10.3.1.1 Increasing adoption of spatial genomics and transcriptomics by biopharma & biotech companies to drive market growth 128
TABLE 144 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 145 GERMANY: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 146 GERMANY: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 147 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 130
TABLE 148 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 130
TABLE 149 GERMANY: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 130
10.3.2 UK 131
10.3.2.1 Rising government support for biotech companies to propel demand for advanced technologies 131
TABLE 150 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 131
TABLE 151 UK: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 131
TABLE 152 UK: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 153 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 132
TABLE 154 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 132
TABLE 155 UK: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 FRANCE 133
10.3.3.1 Increasing investments in life sciences R&D infrastructure development to support market growth 133
TABLE 156 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 133
TABLE 157 FRANCE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 158 FRANCE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 159 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 134
TABLE 160 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 135
TABLE 161 FRANCE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 135
10.3.4 REST OF EUROPE 135
TABLE 162 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 136
TABLE 163 ROE: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 164 ROE: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 165 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 137
TABLE 166 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 137
TABLE 167 ROE: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10.4 ASIA PACIFIC 138
FIGURE 25 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET SNAPSHOT 138
TABLE 168 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 169 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 139
TABLE 170 ASIA PACIFIC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 171 ASIA PACIFIC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 140
TABLE 172 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 140
TABLE 173 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 140
TABLE 174 ASIA PACIFIC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 141
10.4.1 CHINA 141
10.4.1.1 Increasing R&D spending by government and biopharma companies to support market growth 141
TABLE 175 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 142
TABLE 176 CHINA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 177 CHINA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 178 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
TABLE 179 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 143
TABLE 180 CHINA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 143
10.4.2 JAPAN 144
10.4.2.1 Rising funding in Japan to boost research applications 144
TABLE 181 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 144
TABLE 182 JAPAN: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 183 JAPAN: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 184 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 145
TABLE 185 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 186 JAPAN: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 146
10.4.3 INDIA 146
10.4.3.1 Collaborations between hospitals and diagnostics centers for laboratory services to boost growth 146
TABLE 187 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 146
TABLE 188 INDIA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 189 INDIA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 190 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 147
TABLE 191 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 148
TABLE 192 INDIA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 148
10.4.4 REST OF ASIA PACIFIC 148
TABLE 193 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 149
TABLE 194 ROAPAC: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 195 ROAPAC: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 149
TABLE 196 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 150
TABLE 197 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 198 ROAPAC: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 150
10.5 LATIN AMERICA 151
TABLE 199 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 200 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 151
TABLE 201 LATIN AMERICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 202 LATIN AMERICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 152
TABLE 203 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 153
TABLE 204 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 153
TABLE 205 LATIN AMERICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 153
10.5.1 BRAZIL 154
10.5.1.1 Increased adoption of spatial analysis for translational research in Brazil likely to propel market 154
TABLE 206 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154
TABLE 207 BRAZIL: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 208 BRAZIL: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 209 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 155
TABLE 210 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 155
TABLE 211 BRAZIL: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 156
10.5.2 MEXICO 156
10.5.2.1 Growing attention of investors on opportunities in Mexico to support growth 156
TABLE 212 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 156
TABLE 213 MEXICO: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 214 MEXICO: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 157
TABLE 215 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 157
TABLE 216 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 217 MEXICO: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 158
10.5.3 REST OF LATIN AMERICA 158
TABLE 218 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 219 ROLATAM: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 220 ROLATAM: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 221 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 160
TABLE 222 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 160
TABLE 223 ROLATAM: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 160

10.6 MIDDLE EAST & AFRICA 161
TABLE 224 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
TABLE 225 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 161
TABLE 226 MIDDLE EAST & AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 227 MIDDLE EAST & AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 228 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 162
TABLE 229 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 163
TABLE 230 MIDDLE EAST & AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 163
10.6.1 SOUTH AFRICA 163
10.6.1.1 Growing investments in R&D to support market development 163
TABLE 231 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 164
TABLE 232 SOUTH AFRICA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 233 SOUTH AFRICA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 164
TABLE 234 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 165
TABLE 235 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 236 SOUTH AFRICA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 165
10.6.2 REST OF MIDDLE EAST & AFRICA 166
TABLE 237 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 238 ROMEA: SPATIAL TRANSCRIPTOMICS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 239 ROMEA: SPATIAL GENOMICS ANALYSIS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 240 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 167
TABLE 241 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 167
TABLE 242 ROMEA: SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USER, 2020–2027 (USD MILLION) 168
11 COMPETITIVE LANDSCAPE 169
11.1 INTRODUCTION 169
11.2 RIGHT-TO-WIN STRATEGIES ADOPTED BY KEY PLAYERS 169
FIGURE 26 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS 170
11.3 REVENUE SHARE ANALYSIS (TOP SIX PLAYERS) 171
FIGURE 27 REVENUE ANALYSIS FOR TOP SIX COMPANIES, 2018–2021 171
11.4 MARKET SHARE ANALYSIS (2021) 171
FIGURE 28 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: MARKET SHARE ANALYSIS OF TOP SIX PLAYERS (2021) 172
11.5 COMPANY EVALUATION QUADRANT 173
11.5.1 STARS 173
11.5.2 EMERGING LEADERS 173
11.5.3 PERVASIVE PLAYERS 173
11.5.4 PARTICIPANTS 173
FIGURE 29 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT (2021) 174
11.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES 175
11.6.1 PROGRESSIVE COMPANIES 175
11.6.2 STARTING BLOCKS 175
11.6.3 RESPONSIVE COMPANIES 175
11.6.4 DYNAMIC COMPANIES 175
FIGURE 30 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES (2021) 176
11.7 COMPETITIVE BENCHMARKING 177
11.7.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF START-UPS/SMES 177
TABLE 243 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DETAILED LIST OF START-UPS/SMES 177
11.7.1.1 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 178
TABLE 244 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (START-UPS/SMES) 178
11.8 COMPETITIVE SCENARIO AND TRENDS 179
11.8.1 DEALS 179
TABLE 245 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: DEALS 179
11.8.2 PRODUCT LAUNCHES 180
TABLE 246 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: PRODUCT LAUNCHES 180
11.8.3 OTHER DEVELOPMENTS 180
TABLE 247 SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET: OTHER DEVELOPMENTS 180
12 COMPANY PROFILES 181
12.1 MAJOR PLAYERS 181
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 NANOSTRING TECHNOLOGIES 181
TABLE 248 NANOSTRING TECHNOLOGIES: BUSINESS OVERVIEW 181
FIGURE 31 NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT (2021) 182
12.1.2 10X GENOMICS 187
TABLE 249 10X GENOMICS: BUSINESS OVERVIEW 187
FIGURE 32 10X GENOMICS: COMPANY SNAPSHOT (2021) 187
12.1.3 ILLUMINA 191
TABLE 250 ILLUMINA: BUSINESS OVERVIEW 191
FIGURE 33 ILLUMINA: COMPANY SNAPSHOT (2021) 192
12.1.4 BIO-RAD LABORATORIES 197
TABLE 251 BIO-RAD: BUSINESS OVERVIEW 197
FIGURE 34 BIO-RAD: COMPANY SNAPSHOT (2021) 198
12.1.5 BIO-TECHNE 201
TABLE 252 BIO-TECHNE: BUSINESS OVERVIEW 201
FIGURE 35 BIO-TECHNE: COMPANY SNAPSHOT (2021) 202
12.1.6 STANDARD BIOTOOLS 206
TABLE 253 STANDARD BIOTOOLS: BUSINESS OVERVIEW 206
FIGURE 36 STANDARD BIOTOOLS: COMPANY SNAPSHOT (2021) 206
12.1.7 GENOMIC VISION SA 213
TABLE 254 GENOMIC VISION: BUSINESS OVERVIEW 213
FIGURE 37 GENOMIC VISION: COMPANY SNAPSHOT (2021) 213
12.1.8 AKOYA BIOSCIENCES 215
TABLE 255 AKOYA BIOSCIENCES: BUSINESS OVERVIEW 215
FIGURE 38 AKOYA BIOSCIENCES: COMPANY SNAPSHOT (2021) 215
12.1.9 DANAHER CORPORATION 219
TABLE 256 DANAHER CORPORATION: BUSINESS OVERVIEW 219
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 220
12.1.10 NATERA 222
TABLE 257 NATERA: BUSINESS OVERVIEW 222
FIGURE 40 NATERA: COMPANY SNAPSHOT (2021) 223
12.1.11 PERKINELMER 225
TABLE 258 PERKINELMER: BUSINESS OVERVIEW 225
FIGURE 41 PERKINELMER: COMPANY SNAPSHOT (2021) 226
12.1.12 SEVEN BRIDGES GENOMICS 228
TABLE 259 SEVEN BRIDGES GENOMICS: BUSINESS OVERVIEW 228
12.1.13 S2 GENOMICS 229
TABLE 260 S2 GENOMICS: BUSINESS OVERVIEW 229
12.1.14 CANTATA BIO 230
TABLE 261 CANTATA BIO: BUSINESS OVERVIEW 230
12.1.15 VIZGEN CORP 231
TABLE 262 VIZGEN: BUSINESS OVERVIEW 231
12.2 OTHER PLAYERS 232
12.2.1 BIOSPYDER TECHNOLOGIES 232
12.2.2 OPTICAL BIOSYSTEMS 232
12.2.3 MILTENYL BIOTEC 233
12.2.4 RARECYTE 233
12.2.5 ULTIVUE 234
12.2.6 LUNAPHORE TECHNOLOGIES 234
12.2.7 REBUS BIOSYSTEMS 235
12.2.8 RESOLVE BIOSCIENCES 235
12.2.9 SINGULAR GENOMICS 236
12.2.10 VERACYTE 236
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 237
13.1 DISCUSSION GUIDE 237
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 240
13.3 CUSTOMIZATION OPTIONS 242
13.4 RELATED REPORTS 242
13.5 AUTHOR DETAILS 243

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 空間ゲノミクス＆トランスクリプトミクスのアジア太平洋市場予測（～2027）：技術別、製品別、用途別、エンドユーザー別
  • 空間ゲノミクス＆トランスクリプトミクスのグローバル市場（2022年-2029年）：空間トランスクリプトミクス、空間ゲノミクス
  • 空間ゲノミクス＆トランスクリプトミクスのグローバル市場2023-2030：空間トランスクリプトミクス、空間ゲノミクス
  • 空間ゲノミクス・トランスクリプトミクスのグローバル市場2024-2028：翻訳研究、創薬・医薬品開発
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BT7790-23 )"空間ゲノミクス＆トランスクリプトミクスの世界市場予測（～2027）：技術別、製品別、用途別、エンドユーザー別" (英文：Spatial Genomics & Transcriptomics Market by Technique (Spatial Transcriptomics, Spatial Genomics), Product (Instruments, Consumables, Software), Application (Translational Research, Drug Discovery), End User, Global Forecast to 2027)はMarketsandMarkets社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。